Scientific news

New study seeks to determine effectiveness of synthetic cannabis in relieving joint pain in lupus

Researchers at the Feinstein Institute for Medical Research on Long Island, New York have announced they are leading a nationwide clinical trial that will test the efficacy of a synthetic cannabinoid derivative, without mood-altering properties, for the treatment of joint inflammation in lupus.

Federal limits on medical marijuana research hinder patients' relief

The problem stems partly from the fact that the federal government's restrictive marijuana research policies have not been overhauled in more than 40 years, researchers say.

Legal marijuana Is lessening the opioid epidemic, 2 new studies show

According to two newly published studies in JAMA Internal Medicine, medical and recreational pot may offer a benefit to the American public: a reduction in opioid use.

Pharmaceutical giants are sidestepping US marijuana restrictions to research cannabis-based drugs

Federal policies restricting marijuana research have made it difficult to study marijuana and produce cannabis-based drugs - but that isn't stopping pharmaceutical companies from doing it.

How Jefferson Health Birthed the United States' First Major Cannabis Research Program

The medical cannabis program in Pennsylvania is about to enter unprecedented territory as it embarks on the nation’s first state-sanctioned research program.

The Latest in Cannabis Research: Spring 2018

Trying to keep track of all the advances in medical cannabis research? Here are some brief summaries of some of the biggest headlines over the last few months

European Doctors Call for Cannabis Medicines to be Mainstreamed.

The European Journal of Internal Medicine (EJIM) has published a special issue for March titled "Cannabis in Medicine."

MMJ BioScience Licensed in Canada to Make Cannabis-based Medicine for Huntington’s Studies

MMJ BioScience to Make Cannabis-based Medicine for Huntington's.

MMJ BioScience has been licensed in Canada to produce cannabis-derived medicines for testing in FDA-approved studies for Huntington’s disease.

More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy.

Cannabinoids are effective as an adjunctive treatment for reducing seizure frequency in pediatric-onset treatment-resistant epilepsy.

CBD may help curb frequency of epileptic seizures

Naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures,